Shared on08 Aug 25
With no significant changes in Exosens' discount rate or future P/E, the consensus analyst price target remained steady at €42.57. What's in the News Exosens announces a share repurchase program for up to 240,000 shares, with repurchased shares to be used for employee performance share plans and offer expiring on October 31, 2025.
Shared on31 Jul 25Fair value Increased 6.24%
Exosens’ valuation outlook remains stable, as both the discount rate and future P/E saw only minimal changes, resulting in an unchanged consensus analyst price target of €40.07. What's in the News Exosens announces a share repurchase program of up to 240,000 shares, not to exceed the shareholder-authorized maximum price, to be used for employee performance share plans; offer expires October 31, 2025.